Sign In
Buy CMND
$1.99
-0.0400 (-1.97%)
At Close: Jul 13, 2026
Why Is Clearmind Medicine (CMND) Stock Up 56% Today?
08:53am, Tuesday, 11'th Apr 2023
Clearmind Medicine (NASDAQ: CMND ) stock is taking off on Tuesday despite a lack of news concerning the psychedelics company. There's no new press releases or filings with the Securities and Exchange
Israel-Based Clearmind Medicine to Present at The OurCrowd Global Investor Summit Sponsored by Greenberg Traurig Tel Aviv
08:30am, Tuesday, 14'th Feb 2023
Dr. Adi Zuloff-Shani PhD., Clearmind's chief executive officer will discuss its Nasdaq IPO with David Huberman, Capital Markets Shareholder at Greenberg Traurig law firm
Israeli- Based Clearmind Medicine to Host Virtual Investor Conference on Psychedelics for Obesity
08:30am, Wednesday, 08'th Feb 2023
The conference will stream live on Tuesday, February 28, at 8:30 AM EST
Hebrew University' Yissum and Israeli Biotech Clearmind Medicine's Psychedelic-Derived Obesity Treatment Presented by Professor Joseph Tam, D.M.D., Ph.D. at Isranalytica 2023
01:48pm, Wednesday, 25'th Jan 2023 InvestorsHub
Hebrew University' Yissum and Israeli Biotech Clearmind Medicine's Psychedelic-Derived Obesity Treatment Presented by Professor Joseph Tam, D.M.D., Ph.D. at Isranalytica 2023
Isranalytica 2023, the Annual meeting of the Israel Analytical Chemical Society, provided Clearmind with the opportunity to garner visibility for its drug candidate MEAI from attendees at one of the largest annual analytical chemistry conferences in the world
Tel Aviv, Israel / Vancouver, Canada, Jan. 2...
